Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.
about
Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.Integration versus disintegration: a grounded theory study of adolescent and young adult development in the context of perinatally-acquired HIV infectionPubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatmentBone mineral density in children and adolescents with perinatal HIV infectionLower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.Body mass index and waist circumference of HIV-infected youth in a Miami cohort: comparison to local and national cohorts.Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) studyPhysical fitness in children infected with the human immunodeficiency virus: associations with highly active antiretroviral therapyGrowth and body composition of uninfected children exposed to human immunodeficiency virus: comparison with a contemporary cohort and United States National StandardsCardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study.HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.High Burden of Morbidity and Mortality but Not Growth Failure in Infants Exposed to but Uninfected with Human Immunodeficiency Virus in Tanzania.Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children.The Association of Fat and Lean Tissue with Whole Body and Spine Bone Mineral Density is Modified by HIV Status and Sex in Children and Youth.Anthropometry and body composition of vertically HIV-infected children and adolescents under therapy with and without protease inhibitors.PHYSICAL ACTIVITY AND BODY FAT IN ADOLESCENTS LIVING WITH HIV: A COMPARATIVE STUDY.Long-term body composition and metabolic changes in HIV-infected children switched from stavudine to tenofovir and from protease inhibitors to efavirenz.Changes in Insulin Sensitivity over Time and Associated Factors in HIV-Infected Adolescents.Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
P2860
Q30576375-6EBB5AD8-3E98-4CFB-A639-BFC910B2705AQ33896021-4D8403F6-2C54-499D-A87B-87728349B1ABQ34083742-E921D0DE-2FFD-49EC-9F6E-0BF4C5ABCB15Q34150394-DE1A1078-BEAD-4F08-9B52-B480DF00D008Q35659264-0575F186-28AB-4CC1-BECB-CE84EC99A815Q35915204-3BC2284D-83D3-4DDB-BD33-68417D702A92Q35945312-57BB60F4-3FAF-48F9-9544-79663722F728Q36388998-345B5415-5192-44E5-B562-89BD6E02F71FQ36509694-3348B5A6-D499-44DC-9CCA-699CE1998F0DQ36809068-3B722E93-6B49-4D4F-B743-D21CCBBD7C5FQ36941650-CFF214F8-BDFA-4859-ABE2-BF2061091531Q37007002-CEE4EED0-E3B3-45E6-BFEA-A82C6C749D4CQ38021848-2F4A1352-5A8A-4B7E-B328-937F5E774758Q38801878-1FCE88EF-8AA2-42E5-8DF0-A10FAB15A658Q40080607-95C34B2D-35D4-423C-850C-26948D6E5ECCQ40087344-75495397-DCD1-4714-ADCD-DAF48673061BQ40089986-11C33C2C-11A3-4CCD-890E-3F3B1680BABBQ42200499-2A95E509-E712-4A86-87D6-BF45A0883485Q43089961-E076742B-485B-4F83-B91A-085B05A246D2Q44677110-24170314-5CFF-4DBF-B766-DA199449D390Q47559875-0D9651C6-B218-4DE0-A589-C8F343570FF4Q47602387-87185516-2931-4328-B57B-507EA03D0693
P2860
Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Body fat distribution in perin ...... diatric HIV/AIDS Cohort Study.
@ast
Body fat distribution in perin ...... diatric HIV/AIDS Cohort Study.
@en
type
label
Body fat distribution in perin ...... diatric HIV/AIDS Cohort Study.
@ast
Body fat distribution in perin ...... diatric HIV/AIDS Cohort Study.
@en
prefLabel
Body fat distribution in perin ...... diatric HIV/AIDS Cohort Study.
@ast
Body fat distribution in perin ...... diatric HIV/AIDS Cohort Study.
@en
P2093
P2860
P356
P1476
Body fat distribution in perin ...... ediatric HIV/AIDS Cohort Study
@en
P2093
Denise L Jacobson
Elizabeth J McFarland
George K Siberry
Janet S Chen
Kunjal Patel
Margarita Silio
Mitchell E Geffner
Pediatric HIV/AIDS Cohort Study
Roger A Fielding
Russell B Van Dyke
P2860
P304
P356
10.3945/AJCN.111.020271
P407
P577
2011-11-02T00:00:00Z